BOCA RATON, FL )WFLX)-- Three construction workers were injured Tuesday when a deck they were working on collapsed, according to Boca Raton Fire Rescue. Officials said the workers were at the constructionMore >>
Three construction workers were injured Tuesday when a deck they were working on collapsed in Boca RatonMore >>
WEST PALM BEACH, FL (WFLX)-- One of the parents accused of battery on a Palm Beach County School bus driver was released from jail Monday. Shacaurra Burns insists she did not punch the driver last Monday. "IMore >>
One of the parents accused of battery on a Palm Beach County School bus driver speaks out.More >>
BOYNTON BEACH, FL (WFLX) - Area churches are preparing for Easter services, but one local church will be hosting service in an unlikely place. Now, at the Boynton Beach mall, there's a new church whereMore >>
Area churches are preparing for Easter services, but one local church will be hosting service in an unlikely place.More >>
WEST PALM BEACH, FL (WFLX) - Deputies from Palm Beach Sheriff's Office took over a drug suspect's West Palm Beach home and then posed as dealers, netting at least 10 arrests on heroin charges. The PalmMore >>
Deputies from Palm Beach Sheriff's Office took over a drug suspect's West Palm Beach home and then posed as dealers, netting at least 10 arrests on heroin charges.
Friday, April 18 2014 3:34 PM EDT2014-04-18 19:34:46 GMT
PEMBROKE PINES, FL (PEMBROKE PINES PD/CNN) – A judge in Florida was a bit surprised when an aptly named suspect, Edward Cocaine, appeared before him on charges of drug possession. Oddly enough, it wasn'tMore >>
Edward Cocaine was arrested earlier this week after police pulled him over and discovered drugs he did not have a prescription for.More >>
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
Biologics are complex molecules manufactured through cell culture recombinant DNA technology. Biologics additionally comprise recombinant insulin, growth hormone and monoclonal antibodies for treating conditions such as cancer and autoimmunity. Also known as follow-on biologics or subsequent entry biologics (SEBs), biosimilars are to biologics what generics are to branded drugs; they lower healthcare expenditures. This report anticipates that the global biologic drugs market will jump to over $220 billion by 2019.
The study describes the emergence of biologics and biosimilars and their potential role in shaping the future of the global healthcare industry. The study analyzes the changing dynamics of the pharmaceutical market and provides insight into the regulatory pathways for branded pharmaceuticals and biologics, patent expirations, business strategies, clinical trials and drug applications.
Biologics, also known as biopharmaceuticals, can be categorized into three main modalities: therapeutic proteins, monoclonal antibodies and vaccines. Most of the biologic drugs marketed so far are recombinant therapeutic protein drugs, which are used to relieve patients suffering from chronic diseases, such as cancer, diabetes, cardiovascular diseases, infertility and cystic fibrosis. Globally, the U.S. commands 43% of biologics sales, followed by the E.U. (21%) and Japan (9%).
Key biologics and biosimilars are covered by the report, including Humira (Adalimumab), Remicade (Infliximab), Lantus (Insulin Glargine), Levemir (Insulin Detemir), Privigen (Immune Globulin Intravenous), Aranesp (Darbepoetin Alfa), Enbrel (Etanercept), Herceptin (Trastuzumab) and Remicade (Infliximab). Moreover, this report examines companies that are actively developing and marketing biologics and biosimilars in the world. Detailed tables and charts with sales forecasts and marketshare data are also included.